Browsing Tag
pharma manufacturing
2 posts
AstraZeneca strikes $50bn U.S. deal to lower drug prices while reshoring manufacturing amid tariff freeze
AstraZeneca inks $50B U.S. deal to cut drug prices and boost onshore manufacturing. See what this means for patients, profits, and pharma’s policy future.
Dishman Carbogen Amcis (NSE: DCAL) to expand ADC manufacturing in Switzerland
Dishman Carbogen Amcis expands Swiss ADC manufacturing with CHF 25M co-investment. Learn how this aligns with its global CDMO strategy.